Literature DB >> 17523841

Selection bias in cancer risk estimation from A-bomb survivors.

Donald A Pierce1, Michael Vaeth, Yukiko Shimizu.   

Abstract

We consider the possible bias in cancer risk estimation from A-bomb survivors due to selection of the cohort by survival. The paper considers both relevant information from the data and basic theoretical issues involved. The most direct information from the data comes from making various restrictions on the dose-distance range, partly to reduce differential selection and partly just to reduce the magnitude of the selection. These analyses suggest that there are no serious biases, but they are not conclusive. Theoretical considerations include laying out more explicitly than usual just how biases could result from the selection. This involves heterogeneities in the ability to survive acute effects, in baseline and radiogenic cancer rates, and most importantly the correlation between survival-related and cancer-related heterogeneities. Following on this, idealized modeling is used to quantify the extent of possible bias in terms of the assumed values of the magnitude of these heterogeneities and their correlation. It is indicated that these values would need to be very large to introduce substantial bias. Based on all these considerations, it seems unlikely that the bias in cancer risk estimation could be large in relation to other uncertainties in generalizing from what is seen among A-bomb survivors; in particular, indications are that the bias in relative risks is unlikely to be as large as 0.05 to 0.07. For solid cancer this would correspond to bias in the excess relative risk at 1 Sv of at most about 15-20%.

Entities:  

Mesh:

Year:  2007        PMID: 17523841     DOI: 10.1667/RR0349.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  6 in total

1.  Missing doses in the life span study of Japanese atomic bomb survivors.

Authors:  David B Richardson; Steve Wing; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2013-02-20       Impact factor: 4.897

2.  Selection of reference groups in the Life Span Study of atomic bomb survivors.

Authors:  Benjamin French; John Cologne; Ritsu Sakata; Mai Utada; Dale L Preston
Journal:  Eur J Epidemiol       Date:  2017-12-04       Impact factor: 8.082

3.  Positive associations between ionizing radiation and lymphoma mortality among men.

Authors:  David B Richardson; Hiromi Sugiyama; Steve Wing; Ritsu Sakata; Eric Grant; Yukiko Shimizu; Nobuo Nishi; Susan Geyer; Midori Soda; Akihiko Suyama; Fumiyoshi Kasagi; Kazunori Kodama
Journal:  Am J Epidemiol       Date:  2009-03-06       Impact factor: 4.897

4.  Population Density in Hiroshima and Nagasaki Before the Bombings in 1945: Its Measurement and Impact on Radiation Risk Estimates in the Life Span Study of Atomic Bomb Survivors.

Authors:  Benjamin French; Sachiyo Funamoto; Hiromi Sugiyama; Ritsu Sakata; John Cologne; Harry M Cullings; Kiyohiko Mabuchi; Dale L Preston
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

Review 5.  Non-Hodgkin lymphomas and ionizing radiation: case report and review of the literature.

Authors:  Inge Schmitz-Feuerhake; Rainer Frentzel-Beyme; Roland Wolff
Journal:  Ann Hematol       Date:  2021-12-08       Impact factor: 3.673

6.  Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003.

Authors:  Yukiko Shimizu; Kazunori Kodama; Nobuo Nishi; Fumiyoshi Kasagi; Akihiko Suyama; Midori Soda; Eric J Grant; Hiromi Sugiyama; Ritsu Sakata; Hiroko Moriwaki; Mikiko Hayashi; Manami Konda; Roy E Shore
Journal:  BMJ       Date:  2010-01-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.